×
The Offensive Subtype of Taijin-Kyofu-Sho in New York City: The Phenomenology and Treatment of a Social Anxiety Disorder PDF
$ 40.00
The Offensive Subtype of Taijin-Kyofu-Sho in New York City: The Phenomenology and Treatment of a Social Anxiety Disorder PDF quantity
$ 40.00
×
Childhood Maltreatment and Lifetime Suicidal Behaviors Among New Soldiers in the US Army: Results From the Army Study to Assess Risk and Resilience in Servicemembers (Army STARRS) PDF
$ 40.00
Childhood Maltreatment and Lifetime Suicidal Behaviors Among New Soldiers in the US Army: Results From the Army Study to Assess Risk and Resilience in Servicemembers (Army STARRS) PDF quantity
$ 40.00
×
Trends in Incident Varenicline Prescribing Among Veterans Following the US Food and Drug Administration Drug Safety Warnings PDF
$ 40.00
Trends in Incident Varenicline Prescribing Among Veterans Following the US Food and Drug Administration Drug Safety Warnings PDF quantity
$ 40.00
×
Dosing Quetiapine in Drug-Naive First-Episode Psychosis: A Controlled, Double-Blind, Randomized, Single-Center Study Investigating Efficacy, Tolerability, and Safety of 200 mg/day vs. 400 mg/day of Quetiapine Fumarate in 141 Patients Aged 15 to 25 Years PDF
$ 40.00
Dosing Quetiapine in Drug-Naive First-Episode Psychosis: A Controlled, Double-Blind, Randomized, Single-Center Study Investigating Efficacy, Tolerability, and Safety of 200 mg/day vs. 400 mg/day of Quetiapine Fumarate in 141 Patients Aged 15 to 25 Years PDF quantity
$ 40.00
×
A 3-Times-Daily Dosing Scheme of Prazosin to Treat Posttraumatic Stress Disorder–Induced Psychological Distress in the Hospital PDF
$ 40.00
A 3-Times-Daily Dosing Scheme of Prazosin to Treat Posttraumatic Stress Disorder–Induced Psychological Distress in the Hospital PDF quantity
$ 40.00
×
Valproate Prescribed to Reproductive-Age Women in Ambulatory Care: Analysis of 2018–2019 National Ambulatory Health Care Data PDF
$ 40.00
Valproate Prescribed to Reproductive-Age Women in Ambulatory Care: Analysis of 2018–2019 National Ambulatory Health Care Data PDF quantity
$ 40.00
×
Serum Prolactin Levels Among Outpatients With Major Depressive Disorder During the Acute Phase of Treatment With Fluoxetine PDF
$ 40.00
Serum Prolactin Levels Among Outpatients With Major Depressive Disorder During the Acute Phase of Treatment With Fluoxetine PDF quantity
$ 40.00
×
The Mental Health Characteristics of Pregnant Women With Depressive Symptoms Identified by the Edinburgh Postnatal Depression Scale PDF
$ 40.00
The Mental Health Characteristics of Pregnant Women With Depressive Symptoms Identified by the Edinburgh Postnatal Depression Scale PDF quantity
$ 40.00
×
Machine Learning Prediction of Quality of Life Improvement During Antidepressant Treatment of Patients With Major Depressive Disorder: A STAR*D and CAN-BIND-1 Report PDF
$ 40.00
Machine Learning Prediction of Quality of Life Improvement During Antidepressant Treatment of Patients With Major Depressive Disorder: A STAR*D and CAN-BIND-1 Report PDF quantity
$ 40.00
×
Emerging Trends in Opioid Use Disorder Management: A 6-Year Analysis of Emergency Department Visits, Buprenorphine Prescriptions, and Naloxone Distribution (2016–2021) PDF
$ 40.00
Emerging Trends in Opioid Use Disorder Management: A 6-Year Analysis of Emergency Department Visits, Buprenorphine Prescriptions, and Naloxone Distribution (2016–2021) PDF quantity
$ 40.00
×
Common Methods of Suicide and Self-Inflicted Poisoning/Injury by Individuals With Major Depressive Disorder and Bipolar Disorder: A Nationwide Inpatient Sample Analysis PDF
$ 40.00
Common Methods of Suicide and Self-Inflicted Poisoning/Injury by Individuals With Major Depressive Disorder and Bipolar Disorder: A Nationwide Inpatient Sample Analysis PDF quantity
$ 40.00
×
The Role of the Alliance in the Pharmacologic Treatment of Depression PDF
$ 40.00
The Role of the Alliance in the Pharmacologic Treatment of Depression PDF quantity
$ 40.00
×
Efficacy of Antipsychotic Drugs Against Hostility in the European First-Episode Schizophrenia Trial (EUFEST) PDF
$ 40.00
Efficacy of Antipsychotic Drugs Against Hostility in the European First-Episode Schizophrenia Trial (EUFEST) PDF quantity
$ 40.00
×
Hypercalcemia and Psychosis: Case Report, Review of the Literature, and Management Considerations PDF
$ 40.00
Hypercalcemia and Psychosis: Case Report, Review of the Literature, and Management Considerations PDF quantity
$ 40.00
×
Quetiapine-Induced Galactorrhea With Normal Prolactin Level in an Adult Female Patient PDF
$ 40.00
Quetiapine-Induced Galactorrhea With Normal Prolactin Level in an Adult Female Patient PDF quantity
$ 40.00
×
Practical Diagnosis and Management of Dementia Due to Alzheimer's Disease in the Primary Care Setting: An Evidence-Based Approach PDF
$ 40.00
Practical Diagnosis and Management of Dementia Due to Alzheimer's Disease in the Primary Care Setting: An Evidence-Based Approach PDF quantity
$ 40.00
×
Outcomes of Late-Life Anxiety Disorders During 32 Weeks of Citalopram Treatment PDF
$ 40.00
Outcomes of Late-Life Anxiety Disorders During 32 Weeks of Citalopram Treatment PDF quantity
$ 40.00
×
Buspirone in the Management of Anxiety and Irritability in Children With Pervasive Developmental Disorders: Results of an Open-Label Study PDF
$ 40.00
Buspirone in the Management of Anxiety and Irritability in Children With Pervasive Developmental Disorders: Results of an Open-Label Study PDF quantity
$ 40.00
×
GLP-1 Receptor Agonists for Clozapine-Induced Weight Gain: A Case Report With the Dual GLP-1/GIP Agonist Tirzepatide PDF
$ 40.00
GLP-1 Receptor Agonists for Clozapine-Induced Weight Gain: A Case Report With the Dual GLP-1/GIP Agonist Tirzepatide PDF quantity
$ 40.00
×
Safety of Selegiline Transdermal System in Clinical Practice: Analysis of Adverse Events From Postmarketing Exposures PDF
$ 40.00
Safety of Selegiline Transdermal System in Clinical Practice: Analysis of Adverse Events From Postmarketing Exposures PDF quantity
$ 40.00
×
Successful Pharmacologic Treatment of Major Depressive Disorder Attenuates Amygdala Activation to Negative Facial Expressions: A Functional Magnetic Resonance Imaging Study PDF
$ 40.00
Successful Pharmacologic Treatment of Major Depressive Disorder Attenuates Amygdala Activation to Negative Facial Expressions: A Functional Magnetic Resonance Imaging Study PDF quantity
$ 40.00
Coupon: Apply coupon
Update cart